Clearance Summary
MODIFICATION TO PAXGENE BLOOD RNA SYSTEM received FDA 510(k) clearance under submission number K082150, sponsored by Preanalytix GmbH. The device was reviewed via the Special premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2009-02-04.
- Submission: K082150
- Applicant / Sponsor: Preanalytix GmbH
- Clearance pathway: Special
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.4070
- Decision date: 2009-02-04
Classification & Regulation
This clearance is catalogued under FDA product code NTW and 21 CFR 866.4070, within the Immunology review panel as a Class II device.